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Abstract 
The study argues that potential savings from efficiency could be effective alternative to 
increasing health system financing in SSA. Health system efficiency estimates were derived 
from the Data Envelopment Analysis and Stochastic Frontier Analysis and used to compute 
potential gains from efficiency. Data was sourced from the World Bank's world development 
indicators for 45 SSA countries in 2011. The results reveal that average potential saving in 
health expenditure from improved efficiency was 0.10% and 0.75% of GDP per capita in the 
DEA and SFA models, respectively. The results also showed that a 1% increase in efficiency of 
health expenditure reduced infant mortality rate by 0.91% compared to 0.40% reduction in infant 
mortality if health expenditure increased by 1%. The results imply that in the face of significant 
economic challenges and burden on government budget, improving health expenditure efficiency 
to create some fiscal space will be an important step.   
Keywords: Fiscal space for health, health expenditure, DEA, SFA 
JEL classification: H5, I1 
 
 
 
 
 
 
 
 
2 
 
1. Introduction 
Health financing remains a major constraint to effective health service delivery worldwide, 
notably in developing countries which experience significant gabs between population health 
demands and financing. In sub-Saharan Africa (SSA) in particular, the lack of sufficient 
resources committed to the health sector has limited improvements in population health 
conditions, instigating several efforts by global and local non-governmental actors to improve 
investments in the health sector. Such efforts include the Abuja Declaration of 2001, which 
required governments to allocate a minimum of 15% of annual national budgets to the health 
sector. Fourteen years after the declaration, few countries (Rwanda, Malawi, Madagascar, 
Liberia, Togo and Zambia)
1
 have achieved the target. Many other countries are still far from 
achieving the target.  
An emerging concept directed towards increased and sustainable resource commitment to the 
health sector is Fiscal Space for Health (FSH). The concept seeks to identify opportunities for 
governments to raise additional funds for the health sector without jeopardizing the financial 
position of the government [1-2]. The idea is to find ways of increasing health resources while 
not compromising sustainability. This concept is particularly important for resource-constrained 
regions such as SSA. In countries of such regions, placing extra burden on government 
budgetary allocations may result in major macroeconomic challenges. 
A widely recognized approach to achieving FSH is by improving efficiency and reducing 
wastages in the use of resources in the health sector. Health systems with low efficiency tend to 
waste significant amount of resources that could hitherto have been saved and re-invested into 
the sector.  In that case, resources committed to the health sector would have ‘increased’ without 
any extra strain on the national budget. 
While this approach has been documented in the theoretical literature on FSH, empirical 
applications have generally been limited. Available studies have either discussed the 
                                                 
1
 These countries had health spending as percent of total government expenditure above 15%, using 2011 data from 
the world development indicators   
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opportunities for efficiency gains in the health sector [3] or provided some quantitative evidence 
of efficiency gains for individual countries at various levels of the health system [1, 4]. Belay 
and Tandon [5] provided evidence from Napal to show that improvement in health system 
efficiency is by far the best option for realizing additional fiscal space for health. They suggested 
interventions in provider payments, drug procurement mechanisms and hospital and district grant 
allocations as effective ways to improve efficiency, hence increase fiscal space for the health 
sector.  
Empirical evidence from Ghana also suggests that while there are prospects for fiscal space in 
the health sector, this may only be achieved through significant improvement in revenue 
collection and major efficiency gains [6]. Powell-Jackson [2] noted that attempts to use improved 
conceptual understanding to conduct rigorous empirical work is still at its infancy. The purpose 
of the current study was, therefore, to estimate available FSH through potential efficiency gains 
(savings on health expenditure from improved efficiency) at the national level and compare this 
across SSA countries. 
2. Concepts of fiscal space for health 
Fiscal space for health is considered to be a relatively novel concept in the health economics 
literature. This has attracted significant attention from policy makers and international 
organizations in the bid to improve health sector resources. Heller [7] provided a general 
definition of fiscal space as  the "capacity of government to provide additional budgetary 
resources for a desired purpose without any prejudice to the sustainability of its financial 
position". In its application to the health sector, fiscal space for health has been defined as the 
"ability of government to increase spending for the health sector without jeopardizing 
government's long term solvency or crowding-out expenditure in other sectors needed to achieve 
other development objectives" [8-9]. 
There are five broad areas identified in the literature as the potential sources of fiscal space in the 
health sector [8-9]. These are (i) conducive macroeconomic conditions including improving 
government revenue and economic growth (ii) making health a priority in government budgets 
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(iii) increasing specific resources (such as taxes) to the health sector (iv) Health grants and 
foreign aid, and (v) increasing efficiency of existing government health outlay. It should be noted 
that with the exception of the last two options, the other sources of FSH are mostly outside the 
direct control of the health sector and are linked to general macroeconomic policies. 
The current study leverages on the last source of FSH and provides empirical evidence to show 
that reducing wastages that exist in government health spending could create additional resources 
that can be re-invested into the health sector. This is particularly important because as posited by 
Powell-Jackson et al. [2], actors of the health sector have direct control on efficiency in the use 
of health resources. Improving efficiency of health expenditure is also important because most 
SSA countries face macroeconomic challenges that limit the extent to which budgetary 
allocations to the health sector can be increased. Moreover, grants and foreign aid to the health 
sector have reached significantly high levels with little room for increases, coupled with the 
reduction in aid from developed countries due to the current global financial challenges. 
3. Methods 
3.1 Empirical Analysis 
The empirical analysis was performed in two stages. The efficiency of health expenditure was 
estimated in the first stage using both the Data Envelopment Analysis (DEA) and Stochastic 
Frontier Analysis (SFA) models. In the second stage, these efficiency scores were used to 
compute potential gains from efficiency for each country included in the analysis. The potential 
efficiency gain showed how much could be saved in terms of per-capita health expenditure at 
maximum efficiency. This was used to represent available FSH from increased efficiency. 
The DEA model 
The methodology adopted in the study follows Fare et al. [10] and Alexander et al. [11] using 
non-parametric linear programming techniques. The analysis starts with an optimization problem 
which determines the available population health outcome of other health systems. A 'best 
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practice' frontier based on a piece-wise linear envelopment of the health expenditure - health 
outcome data for the sample countries, was used to solve the optimization problem. 
Efficiency in the production of population health is measured relative to such a frontier for each 
country. The health systems of countries that operate on (and determine) the frontier are termed 
efficient (with efficiency score of 1.00), while countries operating off the frontier are considered 
inefficient (with efficiency scores less than 1.00). Inefficiency in this case should be understood 
to mean that better population health outcomes could have been attained from the observed 
health expenditure, were performance similar to that of 'best practice' countries. 
To better understand the procedures described above, let S
t
 be the technology that transforms 
health sector expenditure into population health outcomes. This technology can be modelled by 
the output possibility set 
 ( ) : ( , ) 1,...,t t t t t tP x y x y S t T           (1) 
where P
t
(x
t
) denotes the collection of population health output vectors that consume no more that 
the bundle of resources indicated by the resource vector x
t
, during period t. 
The best practice frontier can be empirically estimated as the upper bound of the output 
possibility set, P
t
(x
t
). The output possibility set, P
t
(x
t
), can be estimated empirically by assuming 
that the sample set is made up of observations on j=1,...J countries' health systems, each using 
n=1,...N resources, 
t
jnx , during period t, to generate m=1,...,M population health outcomes, 
t
jmy , 
in period t. Accordingly, P
t
(x
t
) is estimated from the observed set of health expenditures, and 
population health outcomes for all the countries of the sample. 
The empirical construction of the piece-wise linear envelopment of the input possibility set is 
given by 
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where zj is a variable indicating the weighting of each of the health systems. 
The output-based efficiency score for each country's health system for period t can be derived as 
( , )t t to j iF x y = max{θ such that θy
t
 ϵ Pt(xt)} where ( , ) 1t t to j iF x y  .    (3) 
This suggests that a county's health outcomes vector, y
t
, will be located on the efficiency frontier 
when equation (3) has a value of one. However, if equation (3) produces a value less than one, 
the health system must be classified as inefficient relative to best-observed practice. This 
measure can be computed for country j as the solution to the linear programming problem 
( , ) maxt t to j iF x y            (4) 
with θ, z such that 
1
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where the restrictions on the weighting variables, zj, imply a variable returns to scale assumption 
in regard to the underlying technology of health production.  
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The SFA model 
A simple cross sectional SFA model was used in the analysis [12]. The model basically generates 
stochastic error and inefficiency term based on the residuals obtained from an estimated 
production function expressed as follows: 
'
2~ (0, )
~
i i i
i i i
i v
i
y x
v u
v N
u f
  


  
 
  i = 1,..,N     (6) 
where yi represents the logarithm of output of the ith DMU, xi is a vector of inputs and β is the 
vector of technology parameters. The error term Ԑi is composed of a sum of normally distributed 
disturbance (vi) which accounts for measurement and specification error and a one-sided 
disturbance (ui) which measures inefficiency. Both vi and ui are assumed to be independent of 
each other and i.i.d across observations. An exponential assumption [ ~ ( )]i uu   proposed by 
Meensen and VanBroeck [13], was made about the distribution  of the inefficiency term
2
.   
3.2 Computing efficiency gain  
The potential expenditure savings computed in the current study follows Hernandez de Cos and 
Moral-Benito [14]. The starting point is to estimate the following equation that relates health 
outcomes (hi) to per capita expenditure (expi) and efficiency (effi): 
'
1 2 expi i i i ih eff x u              (7) 
where x is a vector of other variables that influence population health and ui is the error term. 
Given the estimated parameters for efficiency and expenditure ( 1

and 2

), respectively, the 
actual per capita health expenditure (exp*) required to achieve the current health status (at 
maximum efficiency) can be computed for the ith country as follows; 
                                                 
2
 for further details on SFA models, see 12. Belotti F, Daidone S, Ilardi G, Atella V: Stochastic frontier analysis 
using Stata. Center for Economic and International Studies Tor Vergata Research Paper Series 2012, 10:1-48. 
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 * 1 max
2
exp expi i ieff eff




          (8) 
The potential health expenditure savings (S*) for the ith country can be expressed as a 
percentage of the country's per capita gross domestic product (GDPpc) as follows; 
*
* exp exp 100i i
pci
S
GDP

           (9) 
where GDPpci is per capita GDP for the ith country. 
The potential savings in per capita health expenditure shows the fiscal space for health available 
for the ith country if efficiency were improved.  
3.3 Data and data source 
Table 1 below gives a detailed description of the variables used in the analysis and their sources. 
Table 1: Variable description and data source 
Variables Description 
Infant mortality rate 
(IMR) 
Main health outcome variable measured as infant deaths per 1000 live 
births 
Per capita health 
expenditure (HEpc)  
Health expenditure per capita measured in constant 2005 international 
dollars 
Real GDP per 
capita (RGDPpc)  
Real GDP per capita measured in constant 2005 international dollars 
DPT Immunization 
(Imm) 
 Percentage of children ages 12-23 months who received DPT 
immunization before 12 months  
Sanitation  Percentage of population using an improved sanitation facility 
HIV prevalence 
rate (HIV) 
Estimated number of adults aged 15-49 years with HIV infection 
expressed as percent of total population in that age group 
Urbanization  Annual urban population growth rate. 
Population aged 
14 years and 
below (Pop1) 
Population age group below or equal to 14 years expressed as percentage 
of total population 
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Population 15-64 
years (Pop2) 
Population age group between 15 and 64 years expressed as percentage of 
total population 
Population 65 
years and above 
(Pop3) 
Population age group above 65 years expressed as percentage of total 
population 
Education Average years of schooling 
Source: Author’s compilation 
Note: All data were sourced from The World Bank's World Development Indicators 
 
Data for the study was obtained from the World Bank’s World Development Indicators (WDI). 
The data were collected across 45 countries in SSA
3
 for the year 2011[15] 
4. Results 
4.1 Descriptive statistics 
Table 2 presents descriptive statistics of the variables included in the model. The mean values, 
standard deviations, minimum and maximum values are presented. On average, annual urban 
population growth rate was about 3.6%. Mean per capita GDP was about US$3630.5  with 
maximum and minimum values of US$349.0 and US$26142.0, respectively. On average, the 
countries included in the analysis spent US$225.4 per capita on health with minimum and 
maximum values of about US$17.0 and US$1642.7, respectively. Average infant mortality rate 
was about 63.2 per 1000 live births. 
Table 2: Descriptive statistics 
Variable* Observation Mean 
Standard 
deviation 
Minimum Maximum 
Urbanization (%) 45 3.61 1.44 -1.90 6.11 
GDP per capita (US$) 45 3630.51 5676.14 349.01 26142.02 
Immunization (%) 45 78.24 18.61 22.00 99.00 
Sanitation (%) 45 35.45 22.40 9.60 97.10 
Per-capita Health 45 225.39 322.26 16.99 1642.71 
                                                 
3
 The following countries were included in the study: Angola, Benin, Burkina Faso, Botswana, Burundi, Cameroon, 
Cape Verde, Central African Republic, Chad, Comoros, Congo Demographic Republic, Congo, Cote d’Ivoire, 
Equatorial Guinea, Eritrea, Ethiopia, Gabon, Ghana, Guinea, Guinea Bissau, Kenya, Lesotho, Liberia, Madagascar, 
Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, South Africa, Sao Tome, 
Senegal, Seychelles, Sierra Leone, Somalia, Sudan, Swaziland, Tanzania, The Gambia, Togo, Uganda and Zambia. 
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expenditure (US$) 
Infant Mortality Rate 45 63.17 25.51 11.90 119.20 
Population under 14 yrs (%) 45 41.45 6.04 20.64 49.92 
Population 15-64 yrs (%) 45 55.20 4.95 47.49 71.32 
Population above 65 yrs (%) 45 3.35 1.23 2.16 8.04 
HIV prevalence (%) 43 5.10 6.58 0.10 26.00 
Education (years) 45 4.50 2.12 1.20 9.40 
Source: Authors' computation 
* Detailed variable definitions and units of measurement are presented in Table 1 above 
4.2 Potential expenditure savings (efficiency gains) 
Table 3 presents potential savings on health expenditure per capita given improvement in health 
expenditure efficiency. The potential expenditure savings are expressed as percentage of each 
country's GDP per capita. The potential expenditure savings differed across countries with some 
countries potentially benefiting significantly from efficiency improvements. The results from the 
DEA analysis show that on average, SSA countries could save per capita health expenditure of 
up to 0.10% and 0.08% of GDP per capita for single and multiple input specifications, 
respectively. A higher average is reported in the SFA model with a potential health expenditure 
saving of about 0.75% of per capita GDP.  
The individual country analysis reveal that, as expected, countries located on the production 
frontier (efficiency score of 1.00) had no potential savings in health expenditure in the DEA 
model. These countries are relatively efficient, using their resources optimally. Examples of such 
countries include Cape Verde, Eritrea, and Seychelles. In both the DEA and SFA models, 
Democratic Republic of Congo recorded the highest potential saving in health expenditure with 
about 0.42% (DEA with single input), 0.39% (DEA with multiple inputs) and 3.32% (SFA) of 
GDP per capita respectively (Table 3). Other countries with relatively high potential saving on 
health expenditure using the single input DEA model include Burundi (0.29%), Liberia (0.26%), 
Central African Republic (0.20%) and Niger (0.19%). 
In the SFA model, other countries with high potential health expenditure savings include Central 
African Republic (2.32%), Niger (1.76%), Burundi (1.75%) and Mali (1.58%).  Countries with 
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the lowest potential saving on health expenditure include Mauritius (0.02%), Seychelles (0.03%) 
and Botswana (0.05%).  
Table 3: Potential savings in health expenditure  
 
DEA Mono Input DEA Multiple Input SFA model 
Country name 
Efficiency 
score 
Potential 
Saving 
Efficiency 
score 
Potential 
Saving 
Efficiency 
score 
Potential 
Saving 
Angola 0.17 0.04 0.17 0.03 0.35 0.49 
Benin 0.42 0.10 0.43 0.09 0.74 0.75 
Botswana 0.65 0.01 0.65 0.01 0.81 0.05 
Burkina Faso 0.33 0.12 0.76 0.04 0.56 1.36 
Burundi 0.38 0.29 0.44 0.24 0.78 1.75 
Cameroon 0.26 0.08 0.26 0.08 0.75 0.48 
Cape Verde 1.00 0.00 1.00 0.00 0.91 0.10 
Central African Rep 0.35 0.20 0.35 0.18 0.56 2.32 
Chad 0.30 0.12 0.54 0.07 0.68 0.95 
Comoros 0.54 0.10 0.61 0.08 0.80 0.71 
Congo, D.R 0.34 0.42 0.34 0.39 0.69 3.32 
Congo, Rep. 0.36 0.04 0.36 0.03 0.67 0.34 
Cote d'Ivoire 0.27 0.10 0.27 0.09 0.78 0.52 
Equatorial Guinea 0.14 0.01 0.18 0.01 0.11 0.13 
Eritrea 1.00 0.00 1.00 0.00 0.86 1.11 
Ethiopia 0.66 0.08 0.87 0.03 0.84 0.65 
Gabon 0.29 0.01 0.29 0.01 0.49 0.14 
Gambia, The 0.44 0.08 0.49 0.06 0.77 0.54 
Ghana 0.50 0.07 0.50 0.06 0.85 0.35 
Guinea 0.37 0.15 0.62 0.09 0.80 0.84 
Guinea-Bissau 0.28 0.15 0.35 0.12 0.71 1.03 
Kenya 0.59 0.06 0.59 0.06 0.91 0.24 
Lesotho 0.27 0.10 0.27 0.09 0.54 1.06 
Liberia 0.39 0.26 0.39 0.24 0.88 0.89 
Madagascar 0.88 0.03 0.88 0.03 0.90 0.44 
Malawi 0.53 0.13 0.53 0.12 0.80 0.97 
Mali 0.28 0.15 0.37 0.12 0.55 1.58 
Mauritania 0.27 0.08 0.27 0.07 0.55 0.80 
Mauritius 0.99 0.00 1.00 0.00 0.92 0.02 
Mozambique 0.42 0.15 1.00 0.00 0.70 1.36 
Namibia 0.54 0.02 0.54 0.02 0.83 0.10 
Niger 0.55 0.19 1.00 0.00 0.75 1.76 
Nigeria 0.25 0.08 0.25 0.07 0.69 0.53 
Rwanda 0.55 0.09 0.56 0.08 0.88 0.42 
Sao Tome 0.31 0.10 0.31 0.09 0.83 0.41 
Senegal 0.48 0.07 0.48 0.06 0.84 0.37 
Seychelles 1.00 0.00 1.00 0.00 0.84 0.03 
Sierra Leone 0.14 0.18 0.15 0.17 0.61 1.44 
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South Africa 0.34 0.02 0.35 0.01 0.53 0.18 
Sudan 0.31 0.08 0.36 0.07 0.84 0.33 
Swaziland 0.21 0.04 0.21 0.03 0.35 0.53 
Tanzania 0.52 0.08 0.52 0.07 0.90 0.29 
Togo 0.37 0.16 0.37 0.15 0.74 1.14 
Uganda 0.37 0.12 0.37 0.11 0.88 0.38 
Zambia 0.47 0.08 0.47 0.08 0.83 0.47 
Mean 0.45 0.10 0.50 0.08 0.72 0.75 
Source: Authors' computation 
Note: Potential savings on health expenditure are expressed as percent of each country’ GDPpc. 
4.3 Efficiency, health expenditure and health outcomes 
Results in Table 4 show the relationship between efficiency, health expenditure and health 
outcomes. The idea was to find out if increasing health expenditure and improving efficiency in 
the use of this expenditure influence health outcomes differently. All models used infant 
mortality rate as health outcome. The efficiency variables in Models 1 and 2 are from single and 
multiple inputs specifications, respectively. The results show that health expenditure efficiency 
significantly improved infant mortality rate with elasticities of approximately -0.91 and -0.80 in 
models 1 and 2, respectively. This implied that a 1% increase in health expenditure efficiency 
would translate into a reduction in infant mortality rate by 0.91% and 0.80% in models 1 and 2, 
respectively. In the SFA model, a 1% increase in efficient leads to a 1.13% reduction in infant 
mortality rate. 
On the other hand, the results also show that health expenditure per capita has negative 
relationship with infant mortality rate, irrespective of the model specification. The relationship 
was however only significant for Models 1 and 2. The estimated elasticity for per capita health 
expenditure in Model 1 was about -0.40 while that of Model 2 was about -0.35. This suggests 
that a 1% increase in per capita health expenditure would reduce infant mortality by about 0.40% 
and 0.35% in Models 1 and 2, respectively. A general observation show that health system 
efficiency has a higher impact on infant mortality compared to per capita health expenditure.   
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Table 3: Efficiency and population health 
Variables Model 1 Model 2 Model 3 
Lnefficiency -0.90585*** -0.79634*** -1.12666*** 
 
(0.02897) (0.05378) (0.18089) 
LnHCEpc -0.40412*** -0.35480*** -0.02974 
 
(0.03235) (0.06433) (0.11278) 
LnHIV 0.02701** 0.07144*** -0.01615 
 
(0.00995) (0.02033) (0.03878) 
Lnpop1 -0.45065 -0.69835 1.87358 
 
(0.37595) (0.77148) (1.37981) 
Lnpop2 -0.47901 -1.08397 1.66604 
 
(0.51000) (1.04276) (1.92433) 
Lnpop3 -0.06578 -0.1188 -0.12061 
 
(0.08385) (0.16923) (0.32481) 
Lnurbanization 0.01917 0.01976 -0.12412 
 
(0.04953) (0.10009) (0.18895) 
Lnsanitation -0.01986 -0.09845** -0.11589 
 
(0.01969) (0.03922) (0.07504) 
LnGDPpc 0.03898 0.09025* -0.22677** 
 
(0.02560) (0.05234) (0.09962) 
Lneducation -0.02647 -0.39915*** 0.01468 
 
(0.02536) (0.05365) (0.09974) 
Constant 8.58203** 12.28921* -7.45126 
 
(3.33183) (6.83989) (12.47097) 
Source: Authors' computation 
Note: *** significant at 1%; ** significant at 5%; * significant at 10%. Model 1 and 2 have 
efficiency variables from DEA specification with mono (single) and multiple inputs, 
respectively. Model 3 has efficiency variable from the SFA model 
5. Discussions 
In general the findings of the study suggest the presence of some level of FSH across countries in 
SSA. Such FSH can be derived by improving efficiency of health expenditure.  
The individual country analysis suggest that SSA countries have some potential fiscal space for 
health (or potential savings on health expenditure). This conforms with the findings of 
Hernandez de Cos and Moral-Benito [14] who found that potential efficiency gains in the health 
sector and the savings in health expenditure, thereof, are high. Similar conclusions were also 
drawn by Belay and Tandon [5] in the case of Nepal and Okwero et al. [1] in the case of Uganda. 
The findings suggest that a good alternative to increasing health expenditure could be by 
improving efficiency in health care system management. For countries where resources are 
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available for investment in the health sector, the two (increased health spending and improved 
efficiency) could be complementary. Otherwise, the former could follow the latter for better 
results. The results also suggest that the magnitude of efficiency savings vary with the efficiency 
model estimated. Estimates from the SFA model was significantly higher than those from the 
DEA models. In the DEA models it was also observed that the results from the single input 
specification was higher than that of the multiple input specification. However, the rank (in terms 
of performance) of the individual countries was consistent across the models.           
The results from the regression analysis showed a generally significant relationship between 
health expenditure efficiency, health expenditure and health outcomes in SSA. The relationship 
was higher for the efficiency variable relative to the health expenditure variable. This suggests 
that improving efficiency could actually have higher effect on health outcomes than simply 
increasing health expenditure. This supports the argument that governments should go beyond 
increasing health expenditure to ensuring that these resources are used efficiently. Similarly, 
debates about health spending need not focus too much on just raising spending but actually 
improving the efficiency of the spending. Increasing health expenditure is considered as a 
necessary condition to health outcome improvement while improving efficiency becomes a 
sufficient condition. 
In many developing countries, such as SSA, the evidence of a high and significant impact of 
health system efficiency on health outcomes is critical. This is because most of these countries 
face unlimited social and economic challenges with very limited resources. This problem of 
scarcity cripples progress and development of many sectors of the economy, including the health 
sector. Cutting wastes by improving efficiency and savings (in economic terms) should become 
an essential public sector strategy. Such improvements create fiscal space that provides avenue 
for governments to raise additional resources for the health sector. 
This evidence calls for cogent attempts by governments to improve efficiency in the health 
sector. The introduction of appropriate policies, effective monitoring and evaluation and 
sufficient remuneration for health sector workers could play important roles in improving health 
system efficiency. Novignon [16] provided evidence to show that reduced corruption, quality 
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public sector institutions and access to health care are significant factors in reducing health 
system inefficiencies. 
6. Conclusion 
The purpose of the study was to examine potential fiscal space for health through efficiency 
gains in health expenditure. Using data from 45 SSA countries in 2011, the DEA and SFA 
models were employed to estimate health expenditure efficiency. Efficiency gains were therefore 
computed as potential savings in health expenditure from improved efficiency. The relationship 
between health expenditure efficiency, health expenditure and health outcomes was also 
estimated. 
The results showed potential saving in health expenditure in SSA. This indicates potential fiscal 
space for health that could be explored if health system management was improved. The 
estimates for savings in health expenditure was sensitive to the model used. The results also 
indicated a strong relationship between health expenditure efficiency and health outcomes in 
SSA. A similar relationship was also found for health expenditure and health outcomes even 
though the magnitude of impact was higher for health expenditure efficiency. 
In general, the results confirm the need for governments in the region to increase both heath 
expenditure and efficiency in the use of this expenditure. Improving efficiency of health 
expenditure is particularly important in the sense that most countries face daunting economic 
challenges, hence available fiscal space for health in government budgets are very limited. The 
potential savings from improved health expenditure efficiency, therefore, provide an effective 
alternative that can be explored. 
A limitation of the study lies in its inability to complement the results from aggregated data with 
micro level data. While health production functions in the current study were based on health 
spending and other health sector related variables as inputs, there are important factors beyond 
the control of the health sector but cannot be observed at the aggregate level [17]. 
Complementing such aggregate analysis with micro level analysis could be beneficial for policy. 
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